162 related articles for article (PubMed ID: 31292998)
41. Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review.
Yan W; Zhang G
Acta Haematol; 2016; 136(1):1-15. PubMed ID: 27089249
[TBL] [Abstract][Full Text] [Related]
42. Recurrent
Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
[TBL] [Abstract][Full Text] [Related]
43. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
44. Acute promyelocytic leukemia with apparently normal karyotype: molecular findings and response to all-trans retinoic acid.
Kohno A; Tsuzuki S; Kasai M; Miyamura K; Emi N; Tanimoto M; Saito H
Leuk Lymphoma; 2001 Jun; 42(1-2):151-61. PubMed ID: 11699203
[TBL] [Abstract][Full Text] [Related]
45. Transcription therapy for acute promyelocytic leukaemia.
Douer D
Expert Opin Investig Drugs; 2000 Feb; 9(2):329-46. PubMed ID: 11060680
[TBL] [Abstract][Full Text] [Related]
46. Acute promyelocytic leukemia with a cryptic insertion of RARA into TBL1XR1.
Osumi T; Watanabe A; Okamura K; Nakabayashi K; Yoshida M; Tsujimoto SI; Uchiyama M; Takahashi H; Tomizawa D; Hata K; Kiyokawa N; Kato M
Genes Chromosomes Cancer; 2019 Nov; 58(11):820-823. PubMed ID: 31350930
[TBL] [Abstract][Full Text] [Related]
47. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
Guo W; Wang H; Zhao W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
[TBL] [Abstract][Full Text] [Related]
48. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
Dunkley S; Gibson J; Iland H; Li C; Joshua D
Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
[TBL] [Abstract][Full Text] [Related]
49. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia.
Zhang T; Ma D; Wei D; Lu T; Yu K; Zhang Z; Wang W; Fang Q; Wang J
Anticancer Drugs; 2020 Feb; 31(2):158-168. PubMed ID: 31584454
[TBL] [Abstract][Full Text] [Related]
50. Detection of minimal residual disease in a patient with acute promyelocytic leukemia by RT-PCR: necessity of chemotherapy following ATRA therapy.
Sun T; Takatsuki H; Yamashita S; Yufu Y; Umemura T; Nishimura J; Nawata H
Fukuoka Igaku Zasshi; 1994 Feb; 85(2):52-6. PubMed ID: 8144129
[TBL] [Abstract][Full Text] [Related]
51. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Iaccarino L; Ottone T; Hasan SK; Divona M; Cicconi L; Lavorgna S; Alfonso V; Basso G; Barragán E; Bocchia M; Rego EM; Grimwade D; Voso MT; Lo-Coco F
Leuk Lymphoma; 2018 May; 59(5):1268-1270. PubMed ID: 28838264
[No Abstract] [Full Text] [Related]
52. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
53. [Involvement of PML proteins in treatment of acute promyelocytic leukemia with arsenic trioxide].
Hao R; Su L; Shao Y; Bu N; Ma L; Naranmandura H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):541-551. PubMed ID: 30693698
[TBL] [Abstract][Full Text] [Related]
54. PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.
Cicconi L; Divona M; Ciardi C; Ottone T; Ferrantini A; Lavorgna S; Alfonso V; Paoloni F; Piciocchi A; Avvisati G; Ferrara F; Di Bona E; Albano F; Breccia M; Cerqui E; Sborgia M; Kropp MG; Santoro A; Levis A; Sica S; Amadori S; Voso MT; Mandelli F; Lo-Coco F
Leukemia; 2016 Oct; 30(10):1987-1992. PubMed ID: 27133819
[TBL] [Abstract][Full Text] [Related]
55. PML/RARA inhibits expression of HSP90 and its target AKT.
Piredda ML; Gaur G; Catalano G; Divona M; Banella C; Travaglini S; Puzzangara MC; Voso MT; Lo-Coco F; Noguera NI
Br J Haematol; 2019 Mar; 184(6):937-948. PubMed ID: 30536958
[TBL] [Abstract][Full Text] [Related]
56. Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia.
Koller E; Karlic H; Krieger O; Mistrik M; Michlmayr G; Gadner H; Lutz D; Heinz R; Pittermann E
Ann Hematol; 1995 Feb; 70(2):75-8. PubMed ID: 7880927
[TBL] [Abstract][Full Text] [Related]
57. Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature.
Tang Y; Wang Y; Hu L; Meng F; Xu D; Wan K; Huang L; Li C; Zhou J
Int J Clin Exp Pathol; 2015; 8(11):15294-300. PubMed ID: 26823883
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy.
Peterson JF; He RR; Nayer H; Cuevo RS; Smadbeck JB; Vasmatzis G; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB
Cancer Genet; 2019 Sep; 237():51-54. PubMed ID: 31447065
[TBL] [Abstract][Full Text] [Related]
59. Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia.
Zhu HH; Qin YZ; Lai YY; Shi HX; Liu YR; Jiang B; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):872-8. PubMed ID: 23998577
[TBL] [Abstract][Full Text] [Related]
60. Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?
Grimwade D; Jovanovic JV; Hills RK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):53-61. PubMed ID: 24907017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
